Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The ShortCut™ Continued Access Study Protocol

NCT: NCT06211296 · COMPLETED

NCT IDNCT06211296
StatusCOMPLETED
Start Date2024-07-03
Completion2025-05-12
SponsorPi-cardia (INDUSTRY)
First posted
Last updated

Brief Summary

A Prospective, Multicenter, Non-Randomized, Single-Arm, Open-Label Continued Access Study of the ShortCut™ device (The ShortCut™ CAS).

Frequently Asked Questions

What is The ShortCut™ Continued Access Study Protocol?

The ShortCut™ Continued Access Study Protocol is a clinical trial registered under NCT06211296. Current status: COMPLETED.

What is the status of NCT06211296?

The current status of NCT06211296 (The ShortCut™ Continued Access Study Protocol) is: COMPLETED.

When did The ShortCut™ Continued Access Study Protocol start?

The ShortCut™ Continued Access Study Protocol started on 2024-07-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑